39 studies found for:    pancreatic,cancer,detection | Open Studies
Show Display Options
Rank Status Study
21 Recruiting 18 Fluoro-deoxy-glucose Positrons Emission Tomography Combined With Computed Tomography (18-FDG TEP-CT ) in the Diagnosis of the Degeneration of Intraductal Papillary Mucinous Tumor of the Pancreas
Condition: Tumor
Intervention: Other: 18 fluoro-deoxy-glucose positrons emission tomography combined with computed tomography
22 Recruiting 68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours
Condition: Neuroendocrine Tumours
Intervention: Drug: Diagnostic work up
23 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
Intervention:
24 Not yet recruiting Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer
Condition: Cancer
Intervention: Other: n/a- this is an observational study
25 Recruiting Malignancies in Transplanted Patients
Condition: Neoplasms
Interventions: Other: Referral to a multidisciplinary expert panel at the Uppsala University Hospital after tumor detection;   Drug: Switch from calcineurin inhibitor to an mTOR inhibitor
26 Recruiting TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors
Condition: Patients With Gastroenteropancreatic Neuroendocrine Tumors
Intervention: Drug: 68-Ga-DOTANOC
27 Recruiting Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Conditions: Adult Medulloblastoma;   Childhood Medulloblastoma;   Neuroblastoma;   Neuroendocrine Tumor;   Somatostatinoma
Interventions: Radiation: gallium Ga 68-edotreotide;   Procedure: positron emission tomography/computed tomography;   Radiation: indium In 111 pentetreotide;   Procedure: computed tomography;   Procedure: contrast-enhanced magnetic resonance imaging
28 Recruiting Screening of Postoperative Pulmonary Complications by Electrical Impedance Tomography
Conditions: Pulmonary Disease;   Postoperative Respiratory Complications;   Malignant Neoplasm of Stomach;   Liver Diseases;   Pancreatic Diseases
Intervention:
29 Recruiting Diagnostic Accuracy of Gallium-68-DOTATATE PET/CT Compared to Indium-111-pentetreotide Scintigraphy (SPECT/CT) for Gastroenteropancreatic Neuroendocrine Tumors
Condition: Gastroenteropancreatic Neuroendocrine Tumors
Interventions: Drug: Gallium-68-DOTATATE PET/CT (index test);   Drug: Indium-111-Octreoscan (standard test)
30 Unknown  Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
Condition: Neuroendocrine Tumor
Intervention: Procedure: PET scan with Ga68-DOTANOC
31 Recruiting CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases
Condition: Liver Metastases
Interventions: Biological: anti-CEA CAR-T cells;   Device: Sir-Spheres
32 Recruiting Feasibility Study for Robotic Endomicroscopy to Better Define Resection Strategies (PERSEE)
Conditions: Cancer of Digestive System;   Ovarian Cancer
Intervention: Device: confocal laser endomicroscopy
33 Unknown  Mesothelin as a New Tumor Marker for Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
34 Recruiting Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
Condition: Hepatocellular Carcinoma
Interventions: Procedure: RFA;   Procedure: Radioembolization (SIRT)
35 Recruiting New Imaging Procedure for the Localisation of Insulinoma and Transplanted Islet Cells
Conditions: Endogenous Hyperinsulinaemic Hypoglycaemia;   Transplanted Islet Cells
Intervention: Other: Ga -exendin PET/CT, In- exendin SPECT/CT, MRI
36 Unknown  Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI
Conditions: Hepatocellular Carcinoma;   Hepatitis B;   Hepatitis C
Intervention:
37 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)
38 Recruiting Molecular and Whole-body MR Imaging in Lymphomas
Conditions: Lymphoma;   Hodgkin Disease;   Lymphoma, Non-Hodgkin
Intervention: Other: 68Ga-DOTANOC PET/CT; Diffusion weighted MRI
39 Not yet recruiting Thiopurine Induced Pancreatitis in IBD Patients
Conditions: Pancreatitis;   Inflammatory Bowel Diseases
Intervention: Drug: Azathioprine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years